Global Buspirone Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.

Market Analysis and Insights: Global Buspirone Market
In 2020, the global Buspirone market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Buspirone Scope and Market Size
The global Buspirone market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Buspirone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
5mg
10mg
15mg
30mg

Segment by Application
Hospital
Drug Store

By Company
Bristol Myers Squibb
Apotex
Dr. Reddy's Laboratories
Laboratoires Servier
Teva
AMAG Pharmaceuticals
Mylan
Novartis
Watson Laboratories
Hikma
Wockhardt
Cadila Healthcare
Orion Corporation

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE